HMGN5: a potential oncogene in gliomas (Q39581577)

13 September 2017

title

HMGN5: a potential oncogene in gliomas (English)

1 reference

13 September 2017

Jintao Qu

1

1 reference

13 September 2017

Runmin Yan

2

1 reference

13 September 2017

Juxiang Chen

3

1 reference

13 September 2017

Tao Xu

4

1 reference

13 September 2017

Jingxu Zhou

5

1 reference

13 September 2017

Mei Wang

6

1 reference

13 September 2017

Chao Chen

7

1 reference

13 September 2017

Yong Yan

8

1 reference

13 September 2017

Yicheng Lu

9

1 reference

13 September 2017

publication date

4 March 2011

1 reference

Journal of Neuro-Oncology

13 September 2017

published in

1 reference

13 September 2017

volume

104

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

729-736

1 reference

The new WHO classification of brain tumours

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Molecular pathology of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Antiangiogenic therapy in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Regulation of chromatin structure and function by HMGN proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Characterization of a human gene encoding nucleosomal binding protein NSBP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0558-9

The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21373965

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21373965

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-011-0558-9

1 reference

13 September 2017

1 reference